Liposomal drug targeting in the treatment of Kaposi's sarcoma

Liposomal drug targeting in the treatment of Kaposi's sarcoma

Wernz presents five cases in which patients with AIDS and Kaposi's sarcoma (KS) achieved dramatic reductions in facial edema and edema in the lower extremities following liposomal daunorubicin treatment. Results suggest that this drug may also be safely and effectively used in patients with pul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS patient care and STDs 1996-12, Vol.10 (6), p.362-367
1. Verfasser: Wernz, J C
Format: Artikel
Sprache:eng
Schlagworte:
Acquired immune deficiency syndrome
Adult
AIDS
AIDS/HIV
Antibiotics, Antineoplastic - administration & dosage
Case studies
Daunorubicin - administration & dosage
Drug Carriers
Drug therapy
HIV Infections - complications
Humans
Kaposis sarcoma
Liposomes
Male
Middle Aged
Sarcoma, Kaposi - drug therapy
Sarcoma, Kaposi - virology
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Wernz presents five cases in which patients with AIDS and Kaposi's sarcoma (KS) achieved dramatic reductions in facial edema and edema in the lower extremities following liposomal daunorubicin treatment. Results suggest that this drug may also be safely and effectively used in patients with pulmonary KS.
ISSN:1087-2914
1557-7449
DOI:10.1089/apc.1996.10.362